The surge in popularity of GLP-1 weight-loss medications is beginning to reshape consumer behaviour far beyond healthcare. While these drugs are transforming how people manage their health, they are also having a growing impact on the retail sector.
As consumers taking these treatments reduce calorie intake and curb impulse purchases, retailers are being forced to rethink strategies that have historically relied on selling larger volumes of food products.
Digital health technology provider dacadoo is positioning its platforms as a way for retailers to adapt to this shift by embedding health insights directly into the shopping experience.
How GLP-1 drugs are reshaping retail behaviour
The retail industry has long faced disruption from economic cycles, inflation and shifting consumer habits. However, the rapid uptake of GLP-1 medications such as Ozempic, Wegovy and Mounjaro introduces a new challenge driven by pharmaceutical innovation.
In the US alone, the proportion of adults using GLP-1 drugs has more than doubled in just over a year, reaching 12.4%. With these medications reducing appetite and cravings, early data indicates users may consume up to 39% fewer calories, directly affecting demand for high-calorie snacks and impulse purchases that have traditionally driven retail sales.
For decades, retailers and food producers have focused on products designed to maximise taste and repeat consumption through sugar, salt and fat combinations. GLP-1 drugs disrupt this model by suppressing appetite at a neurological level, reducing cravings for these highly processed foods.
While this shift represents a clear win for public health, it also challenges a retail framework built around increasing basket size and rewarding higher spending through loyalty programmes. As consumer priorities move towards nutrient-dense foods rather than quantity, retailers must rethink how they engage and retain customers.
This changing landscape creates an opportunity for retailers to reposition themselves as health partners rather than simply distributors of food. Consumers navigating new dietary routines, particularly those taking GLP-1 medications, often require guidance on maintaining balanced nutrition while managing lower calorie intake.
Retailers are uniquely placed to provide this support by integrating personalised health insights into their digital platforms, loyalty schemes and in-store experiences. By shifting from transactional relationships to consultative engagement, retailers can build stronger trust and longer-term loyalty with customers.
How dacadoo helps retailers adapt to the GLP-1 era
dacadoo’s Grocery Basket Score (GBS™) has been designed to support this transformation by enabling retailers to evaluate the nutritional quality of products in a shopper’s basket.
The scoring system applies a science-based health scale across food and drink items, helping consumers move away from highly processed products and towards more nutrient-dense alternatives.
Through GBS™, retailers can introduce features such as healthier product swaps, real-time recommendations and loyalty programmes that reward nutritional value rather than purely financial spend. Instead of promotions such as “spend $100, get $5 back”, retailers could incentivise shoppers to reach a defined basket health score and earn rewards for healthier choices.
While GBS™ focuses on product-level insights, dacadoo’s Digital Health Engagement Platform (DHEP) is designed to address the broader behavioural side of health. The platform enables retailers to deliver personalised health coaching, gamified wellness challenges and lifestyle tracking that incorporates nutrition, exercise and sleep data.
By combining behavioural insights with product scoring from GBS™, retailers can provide highly tailored recommendations that guide consumers toward healthier shopping habits while strengthening engagement with their brand.
The integration of DHEP and GBS™ creates a comprehensive ecosystem that helps retailers understand both what customers buy and how they live. This dual insight allows companies to build loyalty systems centred around wellbeing while gaining richer data that can inform merchandising strategies, product development and marketing campaigns.
Retailers could redesign store displays to prioritise nutrient-dense snacks, launch loyalty tiers focused on protein-rich foods or develop private-label products tailored to the dietary needs of health-conscious shoppers.
Implementation is designed to be relatively seamless. dacadoo’s platforms follow an API-first approach, allowing retailers to integrate the technology into existing mobile apps, loyalty programmes and digital ecosystems without requiring a full infrastructure overhaul. The company also emphasises strong data protection standards, enabling retailers to gain behavioural insights while maintaining high levels of consumer privacy and security.
As GLP-1 medications reshape consumer priorities from “more” to “better”, retailers face a critical moment of transformation.
Businesses that move quickly to incorporate health-driven strategies could strengthen loyalty and differentiate themselves in an evolving marketplace. Through its DHEP and GBS™ platforms, dacadoo aims to provide retailers with the tools to navigate this shift and build sustainable growth in an increasingly health-focused retail environment.
Read the full blog from dacadoo here.
Copyright © 2026 FinTech Global
